Sex Differences in α-Synuclein Seed Amplification Assay Parameters and Longitudinal Clinical Subtypes of Parkinson’s Disease
Objective: To investigate differences in baseline α-synuclein seed amplification assay (SAA) metrics and longitudinal clinical subtypes of Parkinson’s disease (PD) between the two biological sexes.…AntiSaccadeNet: A Deep Learning Framework for Differentiating Parkinsonian Disorders through Antisaccade Time Series Classification
Objective: To develop and evaluate a deep learning architecture (AntiSaccadeNet) that utilizes continuous antisaccade eye movement time-series data to differentiate between Parkinson's disease (PD) and…Virtual Reality to Assess for Digital Biomarkers of Visual Hallucinations in Parkinson’s Disease
Objective: Use a novel virtual reality (VR) protocol to evaluate for potential digital biomarkers of visual hallucinations (VH) in Parkinson’s Disease (PD). Background: VH are common…Advancing the regulatory maturity of digital health technologies with focus on early intervention, Critical Path for Parkinson’s 3DT initiative
Objective: To report the feedback from global regulatory agencies to Critical Path Institute (C-Path) on the use of digital health technologies (DHTs) for Parkinson’s disease…Effect of Systematic Survey-based Screening for Depression in Parkinson’s Disease
Objective: To determine the impact of systematic survey-based screening for depression on treatment outcomes in people with Parkinson's disease (PD) in a clinical practice setting. Background: Depression in…The role of interoception in motor imagery in Parkinson’s disease
Objective: The present study explored the relationship between interoceptive awareness and motor imagery in individuals with PD. Background: Motor imagery is the imagination of movement,…Design of the Phase 2, Double-Blind, Placebo-Controlled, Multicenter Study Investigating the Efficacy and Safety of ACP-204, a Novel 5-HT2A Inverse Agonist, in Adults With Lewy Body Dementia Psychosis
Objective: To present the design for a study of ACP-204 efficacy and safety in adults with Lewy body dementia psychosis (LBDP), including Parkinson’s disease dementia…Pilot Feasibility Data using Augmented Reality and Machine Learning-Based Digital Cognitive Assessment in Parkinson’s disease
Objective: To assess the feasibility of using a novel cognitive and functional digital biomarker assessment, the Altoida NeuroMarker platform, to evaluate the presence of MCI…What women want: real-life experiences of women with Parkinson’s disease
Objective: To explore the experiences of women with Parkinson’s disease (WwPD) in healthcare access, physical and mental health, relationships, and future planning, identifying unmet needs.…Critical appraisal of MDS Criteria for diagnosing PD
Objective: To determine the validity of MDS Diagnostic criteria for PD by assessing individual diagnostic criteria in pathologically confirmed PD Background: The 2015 MDS criteria…
- « Previous Page
- 1
- …
- 171
- 172
- 173
- 174
- 175
- …
- 553
- Next Page »